Hot Topics in PVD: New Drugs, New Trials Across the Spectrum of Pulmonary Hypertension in Heart and Lung Disease
20 February, 2024 3:00 p.m. to 4:00 p.m. EST

This webinar will highlight new results from therapeutic studies of PAH, specifically Phase Two and Three Studies in Group 1 PAH, and will present information on new concepts for future PAH trials. Participants will learn the practical concerns for PAH
RCT’s including sample size and study design as well as the relevance of primary and secondary endpoints to clinical practice and discuss any ethical issues.
Moderators
Helen Whitford, MBBS, FRACP
Marc Simon, MD, MS,
Presentations
Click any of the drop downs below to learn more about the specific talks being presented as part of this webinar.
New Results from Therapeutic Studies of PAH: Where We Have Been
Q&A Session
Practical Concerns and New Concepts for PAH Trials: How to Get There
Q&A Session